Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase

Kidney International

Volumn 54, Issue 6, 1998, Pages 1976-1984

  Kazes, Isabelle ^a   Delarue, Françoise ^a   Hagège, Jacqueline ^a   Bouzhir sima, Latifa ^a   Rondeau, Eric ^a   Sraer, Jean Daniel ^a   Nguyen, Geneviève ^a,b  

^a INSERM   (France)

^b HÔPITAL TENON   (France)

Author keywords

Fibrosis; Gelatinase A; Glomerular disease; Glomerulonephritis; MT MMP; Proteinuria; UPA

Indexed keywords

ALPHA 2 MACROGLOBULIN; GELATINASE A; MATRIX METALLOPROTEINASE; MEMBRANE ENZYME; TISSUE INHIBITOR OF METALLOPROTEINASE; UROKINASE;

ARTICLE; CELL SECRETION; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL;

EID: 0031756112     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00216.x     Document Type: Article

References (42)

1. BARICOS WH: Decreased proteolysis of the glomerular extracellular matrix as a pathogenic mechanism in progressive renal disease. J Nephrol 7:322-328, 1994
2. DAVIES M, MARTIN J, THOMAS GJ, LOVETT DH: Proteinases and glomerular matrix turnover. Kidney Int 41:671-678, 1992
3. DAVIES M, THOMAS GJ, MARTIN J, LOVETT DH: The purification and characterization of a glomerular-basement-membrane-degrading neutral proteinase from rat mesangial cells. Biochem J 251:419-425, 1988
4. MARTIN J, DAVIES M, THOMAS GJ, LOVETT DH: Human mesangial cells secrete a GBM-degrading neutral proteinase and a specific inhibitor. Kidney Int 36:790-801, 1989
5. LE QC, SHAH SV, NGUYEN HH, CORTEZ SL, BARICOS WH: A novel metalloproteinase present in freshly isolated rat glomeruli. Am J Physiol 260:F555-F561, 1991
6. JOHNSON R, YAMABE H, CHEN YP, CAMPBELL C, GORDON K, BAKER P, LOVETT DH, COUSER WG: Glomerular epithelial cells secrete a glomerular basement membrane-degrading metalloproteinase. J Am Soc Nephrol 2:1388-1397, 1992
7. BARICOS WH, CORTEZ SL, EL-DAHR SS, SCHNAPER HW: ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 47:1039-1047, 1995
8. NAGASE H, SUZUKI K, MORODOMI T, ENGHILD JJ, SALVESEN G: Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix 1(Suppl):237-244, 1992
9. KESKI-OJA J, LOHI J, TUUTTILA A, TRYGGVASON K, VARTIO T: Proteolytic processing of the 72,000-Da type IV collagenase by urokinase plasminogen activator. Exp Cell Res 202:471-476, 1992
10. LACAVE R, RONDEAU E, OCHI S, DELARUE F, SCHLEUNING WD, SRAER J-D: Characterization of a plasminogen activator and its inhibitor in human mesangial cells. Kidney Int 35:806-811, 1989
11. BROWN PA, WILSON HM, REID FJ, BOOTH NA, SIMPSON JG, MORRISON L, POWER DA, HAITES NE: Urokinase-plasminogen activator is synthesized in vitro by human glomerular epithelial cells but not by mesangial cells. Kidney Int 45:43-47, 1994
12. LOVETT DH, JOHNSON RJ, MARTI H-P, MARTIN J, DAVIES M, COUSER WG: Structural characterization of the mesangial cell type IV collagenase and enhanced expression in a model of immune complex-mediated glomerulonephritis. Am J Pathol 141:85-98, 1992
13. XU Y, HAGÈGE J, MOUGENOT B, SRAER J-D, RØNNE E, RONDEAU E: Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney. Kidney Int 50:2011-2019, 1996
14. WAGNER SN, ATKINSON MJ, WAGNER C, HOFLER H, SCHMITT M, WILHELM O: Sites of urokinase-type plasminogen activator expression and distribution of its receptor in the normal human kidney. Histochem Cell Biol 105:53-60, 1996
15. TURCK J, POLLOCK AS, LEE LK, MARTI H-P, LOVETT DH: Matrix metalloproteinase 2 (Gelatinase A) regulates glomerular mesangial cell proliferation and differentiation. J Biol Chem 271:15074-15083, 1996
16. TOMOSUGI N, SATO H, SEIKI M, YAMAYA H, YURI T, NAKAMURA M, NAKAZAWA T, ASAKA M, ISHIKAWA I: Activation of metalloproteinase-2 by membrane type metalloproteinase expressed on human mesangial cell membrane. Contrib Nephrol 118:135-140, 1996
17. SATO H, TAKINO T, OKADA Y, CAO J, SHINAGAWA A, YAMAMOTO E, SEIKI M: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65, 1994
18. WILL H, ATKINSON SJ, BUTLER GS, SMITH B, MURPHY G: The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. J Biol Chem 271:17119-17123, 1996
19. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
20. YAMAMOTO M, MOHANAM S, SAWAYA R, FULLER GN, SEIKI M, SATO H, GOKASLAN ZL, LIOTTA LA, NICOLSON GL, RAO JS: Differential expression of membrane-type metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro. Cancer Res 56:384-392, 1996
21. MARTIN J, KNOWLDEN J, DAVIES M, WILLIAMS JD: Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int 46:877-885, 1994
22. CAO J, REHEMTULLA A, BAHOU W, ZUCKER S: Membrane type matrix metalloproteinase 1 activates pro-gelatinase A without furin cleavage of the N-terminal domain. J Biol Chem 271:30174-30180, 1996
23. PEI D, WEISS SJ: Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271:9135-9140, 1996
24. CAO J, SATO H, TAKINO T, SEIKI M: The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J Biol Chem 270:801-805, 1995
25. IMAI K, OHUCHI E, AOKI T, NOMURA H, FUJII Y, SATO H, SEIKI M, OKADA Y: Membrane-type matrix metalloproteinase 1 is a gelatinolytic enzyme and is secreted in a complex with tissue inhibitor of metalloproteinase 2. Cancer Res 56:2707-2710, 1996
26. NGUYEN G, LI X-M, PERALDI M-N, ZACHARIAS U, HAGÈGE J, RONDEAU E, SRAER J-D: Receptor binding and degradation of urokinase-type plasminogen activator by human mesangial cells. Kidney Int 46:208-215, 1994
27. BERGMANN U, TUUTTILA A, STETLER-STEVENSON WG, TRYGGVASON K: Autolytic activation of recombinant human 72 kD type IV collagenase. Biochemisty 34:2819-2825, 1995
28. LIM YT, SUGIURA Y, LAUG WE, SUN B, GARCIA A, DECLERCK YA: Independent regulation of matrix metalloproteinases and plasminogen activators in human fibrosarcoma cells. J Cell Physiol 167:333-340, 1996
29. OGATA Y, ENGHILD JJ, NAGASE H: Matrix metalloproteinase 3 (Stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Cell Biol 267:3581-3584, 1992
30. LOHI J, LEHTI K, WESTERMARCK J, KÄHÄRI V-M, KESKI-OJA J: Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 239:239-247, 1996
31. CRABBE T, IOANNOU C, DOCHERTY AJP: Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. Eur J Biochem 218:431-438, 1993
32. SATO H, TAKING T, KINOSHITA T, IMAI K, OKADA Y, STETLERSTEVENSON WG, SEIKI M: Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett 385:238-240, 1996
33. STRONGIN AY, MARMER BL, GRANT GA, GOLDBERG GI: Plasma membrane-dependant activation of 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J Biol Chem 268: 14033-14039, 1993
34. STRONGIN AY, COLLIER I, BANNIKOV G, MARMER BL, GRANT GA, GOLDBERG GI: Mechanism of cell surface activation of 72-kDa type IV collagenase. J Biol Chem 270:5331-5338, 1995
35. CAJOT JF, KRUITHOF EKO, SCHLEUNING WD, SORDAT B, BACHMAN F: Plasminogen activators, plasminogen activators inhibitors and procoagulant analyzed in twenty human tumor cell lines. Int J Cancer 38:719-727, 1986
36. MAZZIERI R, HØYER-HANSEN G, RØNNE E, LØBER D, VAGNARELLI P, RAIMONDI E, CARLI LD, DANØ K, MIGNATTI P: Urokinase and urokinase receptor expression in somatic cell hybrids. Fibrinolysis 8:344-352, 1994
37. MONTGOMERY AMP, DECLERCK YA, LANGLEY KE, REISFELD RA, MUELLER BM: Melanoma-mediated dissolution of extracellular matrix: Contribution of urokinase-dependent and metalloproteinase-dependent proteolytic pathways. Cancer Res 53:693-700, 1993
38. CAROME MA, STRIKER LJ, PETEN EP, ELLIOT SJ, YANG C-W, STETLER-STEVENSON WG, REPONEN P, TRYGGVASON K, STRIKER GE: Assessment of 72-kilodalton gelatinase and TIMP-1 gene expression in normal and sclerotic murine glomeruli. J Am Soc Nephrol 5:1391-1399, 1994
39. MAZZIERI R, MASIERO L, ZANETTA L, MONEA S, ONISTO M, GARBISA S, MIGNATTI P: Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J 16:2319-2332, 1997
40. OKADA A, BELLOCO J-P, ROUYER N, CHENARD M-P, Rio M-C, CHAMBON P, BASSET P: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Natl Acad Sci USA 92:2730-2734, 1995
41. SAWICKI G, SALAS E, MURAT J, MISZTA-LANE H, RADOMSKI MW: Release of gelatinase A during platelet activation mediates aggregation. Nature 386:616-619, 1997
42. PARK S, MARKER LA, MARZEC UM, LEVIN EG: Demonstration of single chain urokinase-type plasminogen activator on human platelet membrane. Blood 73:1421-1425, 1989